The Renal Disease market is accruing and expected to gain further prominence over the forecast period mainly due to the growing prevalence of chronic Renal Disease, technological advancements and availability of effective treatments. According to a recent study report published by the Market Research Future, The global market of Renal Disease is projected to accrue at a rapid pace during the forecast period (2017 – 2023). The Market is forecasted to accrue USD 14291.2 Million by 2023 with a striking CAGR of ~6.3% during 2017 and 2023.
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Global Renal disease Market is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market.
Get a sample report at https://www.marketresearchfuture.com/sample_request/3167 .
Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), and Shire Pharmaceuticals Limited (Republic of Ireland) are some of the prominent players competing in the Global Market of Renal Disease and are profiled in MRFR Analysis.
Most Renal diseases attack the nephrons. This damage may leave kidneys unable to remove wastes. Causes can include genetic problems, injuries, or medicines. Diabetics and high blood pressure patients have a higher risk of kidney disease. Chronic Renal disease damages the nephrons slowly over several years.
A recent study also emphasises on Air pollution that could harm your kidneys. People with Renal Diseases are at increased risk of developing a life-threatening abnormal heart rhythm, a new report suggests. Chronic Renal disease can as much as double a patient’s risk of atrial fibrillation, a quivering or irregular heartbeat that can lead to stroke or heart failure. The risk of atrial fibrillation increases as kidney function declines.
With the number of kidney failure patients expected to continue to rise in the future, healthcare providers are seeking new ways to expand treatment options, improve outcomes, and reduce the chronic health conditions that contribute to the potentially deadly disease.
Kidney transplants which can be performed using a kidney from a deceased donor or an organ from a living donor, if certain biological factors can be matched are only part of the picture. Efforts to find desperately needed donors, both living and dead, can only go so far, and the use of dialysis as a stopgap measure is far from optimal. Despite significant improvements in the surgery and new techniques that allow far more options for matching living donors, there is a significant shortage of available kidneys. As a result, doctors are now looking to stop kidney disease before it starts.
Complete Report Available at https://www.marketresearchfuture.com/reports/renal-disease-market-3167 .
Renal DiseaseMarket – Competitive Analysis
Characterized by the presence of several major players, having international recognition; the global market of Renal Disease appears to be highly fragmented and competitive. Marketers compete based upon price and brand reinforcement. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market and to maintain their market position.
Key Players operating in the market compete based on pricing, innovation and service. In view of growth and immense revenue generation opportunities potential that market is currently demonstrating is in turn attracting several new entrants to enter the Renal Disease market.
Get a discount at https://www.marketresearchfuture.com/check-discount/3167 .
Renal Disease Market – Regional Analysis
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
A vague statistic indicates that 30 million American adults are likely to have chronic kidney disease and most aren’t aware of it. 1 in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history of kidney failure. People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease. African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end stage renal disease.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/renal-disease-market-3167